 VALSARFEC D
|
Fecofar
|
| valsartán+hidroclorotiazida |
Antihipertensivo |
| 160/12.5 mg comp.x 28 | $28.873,46 | (30/03/26) |
| PAMI |
|
| AF $14.063,25 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $13.106,25 |
|
|
|
|
| 160/12.5 mg comp.x 30 | $31.089,00 | (30/03/26) |
| IOMA |
Cobertura Monto Fijo |
| OS $19.399,94 AF $11.689,06 |
|
|
|
|
| 160/25 mg comp.x 30 | $36.114,70 | (30/03/26) |
| IOMA |
Cobertura Monto Fijo |
| OS $24.255,32 AF $11.859,38 |
|
|
|
|
| 160/25mg comp.x 28 | $33.541,02 | (30/03/26) |
| PAMI |
|
| AF $16.770,51 |
|
|
| IOMA |
Cobertura Monto Fijo |
| OS $15.767,21 AF $17.773,81 |
|
|
|
|
| 80/12.5 mg comp.x 28 | $24.872,70 | (30/03/26) |
|
|
|
| 80/12.5 mg comp.x 30 | $26.781,24 | (30/03/26) |
| IOMA |
Cobertura Monto Fijo |
| OS $17.759,00 AF $9.022,24 |
|
|
|
|
| |
